Jonathan Quick

Mr. Quick is the Senior Vice President of Finance at Jade Biosciences, bringing over 15 years of financial leadership in the biotechnology and pharmaceutical sectors. At Jade, he oversees the company’s finance, accounting, and treasury functions.

Prior to joining Jade, he led financial operations at Myeloid Therapeutics, managing key areas such as accounting and treasury. He also held a senior finance role at Alexion Pharmaceuticals, a subsidiary of AstraZeneca, where he directed finance and accounting for the genomic medicines division.

Previously, Mr. Quick played a key role at LogicBio Therapeutics, a Nasdaq-listed biotechnology company acquired by Alexion, overseeing public company reporting, financial planning, and the controllership function. Earlier in his career, he held roles of increasing responsibility at Karyopharm Therapeutics and Celldex Therapeutics. He began his career at PricewaterhouseCoopers LLP, working in the Deals Advisory practice.

Mr. Quick holds a B.S. in Accountancy from Providence College and is a Certified Public Accountant in Massachusetts.